Breaking
Friday, June 19, 2026

Gene Therapy News

🇺🇸 FDA

FDA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 27 articles

High impact NewsJun 11, 2026

Sensorion pivots to SENS-601 after Regeneron’s OTOF hearing loss advance

FDA · hearing loss · 4 min

Dr. Sarah Mitchell
High impact NewsJun 8, 2026

$2M Gene Therapy Cures Need a Financing Model

gene therapy · 4 min

Dr. Sarah Mitchell
Medium impact NewsJun 1, 2026

FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety

FDA · gene therapy · 2 min

Dr. Sarah Mitchell
Critical impact NewsMay 15, 2026

Fierce Biotech Week: Key Takeaways and Emerging Trends

biotech · 12 min

Dr. Laura Bennett
Critical impact NewsMay 14, 2026

ASGCT: Key Manufacturing Innovations Day 1

manufacturing · 12 min

Dr. Laura Bennett
High impact NewsMay 14, 2026

ASGCT 2024: Gene Therapy Advancements Day 1 Roundup

general · 8 min

Dr. Laura Bennett
Critical impact NewsMay 13, 2026

ASGCT 2024: Day 1 Key Takeaways in Gene Therapy Advancements

general · 8 min

Dr. Laura Bennett
Critical impact NewsMay 13, 2026

ASGCT 2026: Gene Therapy Manufacturing Innovations Emerge

manufacturing · 3 min

Dr. Laura Bennett
Critical impact NewsMay 11, 2026

ASGCT: Manufacturing Innovations Take Center Stage

manufacturing · 3 min

Dr. Laura Bennett
Critical impact NewsMay 11, 2026

ASGCT 2024: Gene Therapy Advancements Take Center Stage

general · 8 min

Dr. Laura Bennett
High impact NewsMay 5, 2026

Opus Genetics' OPGx-LCA5 Gene Therapy Accepted Into FDA's Rare Disease Evidence Program

FDA · 2 min

Dr. Natalie Hughes
High impact NewsMay 2, 2026

Restore Vision Reports Positive Safety Data for RV-001 Gene Therapy in Retinitis Pigmentosa Trial

2 min

Dr. Sarah Mitchell